Medline Q2 Sales Surge 11.6% but Net Income Plunges 58% on Fire Loss; Guidance Mixed
MDLN sits 16% above its 52-week low of $32.815.
Summary
Medline reported Q2 2026 results with 11.6% sales growth to $7.7B, but net income fell 58% to $139M due to a $336M distribution center fire loss. Full-year organic sales guidance was raised, but Adjusted EBITDA guidance was cut by $200M, reflecting cost headwinds.
Key Events · Earnings and Guidance · MDLN
-
Q2 Sales Growth Strong, Net Income Plunges
Net sales rose 11.6% to $7.7B, but net income fell 58.3% to $139M, driven by a $336M loss from the Tracy, CA distribution center fire.
-
Adjusted EBITDA Boosted by One-Time Tariff Refunds
Adjusted EBITDA increased 13.4% to $1.06B, including $243M in net IEEPA tariff refund benefits that will not repeat.
-
Full-Year Guidance: Sales Raised, EBITDA Cut
Organic sales growth outlook raised to 9-10%, but Adjusted EBITDA guidance lowered to $3.3-$3.4B (from $3.5-$3.6B) due to inflation, operational investments, and quality remediation costs.
-
Fire Loss and Insurance Uncertainty
The $336M pre-tax loss from the Tracy fire is before expected insurance recoveries; timing and amount of recoveries remain uncertain, posing a risk to future earnings.
Analysis · MDLN · Industrial Applications And Services
Medline delivered strong 11.6% organic sales growth in Q2, driven by existing customer expansion and new signings, but net income collapsed 58% to $139M due to a $336M loss from the Tracy distribution center fire. Adjusted EBITDA rose 13.4% to $1.1B, boosted by $243M in IEEPA tariff refund benefits. The company raised its full-year organic sales growth outlook to 9-10%, reflecting robust demand, but cut Adjusted EBITDA guidance by $200M at the midpoint to $3.3-$3.4B, citing inflationary pressure from the Middle East conflict, operational investments, quality remediation, and retail softness. The fire loss, while partially offset by expected insurance recoveries, introduces uncertainty around operational resilience and future costs. The tariff refunds are a one-time tailwind that will not recur, making the lowered EBITDA guidance a more telling indicator of underlying profitability pressures.
At the time of this filing, MDLN was trading at $38.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $55.2B. The 52-week trading range was $32.82 to $50.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.